HK1171381A1 - Antacid and laxative tablet - Google Patents

Antacid and laxative tablet

Info

Publication number
HK1171381A1
HK1171381A1 HK12112239.2A HK12112239A HK1171381A1 HK 1171381 A1 HK1171381 A1 HK 1171381A1 HK 12112239 A HK12112239 A HK 12112239A HK 1171381 A1 HK1171381 A1 HK 1171381A1
Authority
HK
Hong Kong
Prior art keywords
antacid
laxative tablet
laxative
tablet
Prior art date
Application number
HK12112239.2A
Other languages
English (en)
Chinese (zh)
Inventor
北島秀明
堀江史朗
久保高明
河邊成人
穴吹友孝
Original Assignee
協和化學工業株式會社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 協和化學工業株式會社 filed Critical 協和化學工業株式會社
Publication of HK1171381A1 publication Critical patent/HK1171381A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08Oxides; Hydroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK12112239.2A 2009-09-08 2012-11-28 Antacid and laxative tablet HK1171381A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009206720 2009-09-08
PCT/JP2010/064066 WO2011030659A1 (fr) 2009-09-08 2010-08-20 Comprimé antiacide et laxatif

Publications (1)

Publication Number Publication Date
HK1171381A1 true HK1171381A1 (en) 2013-03-28

Family

ID=43732333

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12112239.2A HK1171381A1 (en) 2009-09-08 2012-11-28 Antacid and laxative tablet

Country Status (13)

Country Link
US (1) US20120156293A1 (fr)
EP (1) EP2476423A4 (fr)
JP (1) JP5696050B2 (fr)
KR (1) KR101560438B1 (fr)
CN (1) CN102481315B (fr)
AU (1) AU2010293637B2 (fr)
BR (1) BR112012005163A2 (fr)
CA (1) CA2772750A1 (fr)
HK (1) HK1171381A1 (fr)
MX (1) MX2012002789A (fr)
RU (1) RU2501561C1 (fr)
TW (1) TWI466689B (fr)
WO (1) WO2011030659A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201401678TA (en) * 2009-04-22 2014-06-27 Kyowa Chem Ind Co Ltd Tablet and pestle therefor
CA2938003C (fr) 2014-02-25 2019-01-08 Konoshima Chemical Co., Ltd. Granules d'oxyde de magnesium destinees a des applications pharmaceutiques ou a un usage comme additifs alimentaires
WO2016175042A1 (fr) * 2015-04-30 2016-11-03 協和化学工業株式会社 Agent médicinal contenant un composé de magnésium en tant qu'ingrédient actif
CN107137233B (zh) * 2017-04-20 2022-09-13 扬州大学 一种具有鸡尾酒疗效口服药片的加工方法
TWI724629B (zh) * 2018-11-16 2021-04-11 日商協和化學工業股份有限公司 緩瀉用錠劑
DE102019213938A1 (de) * 2019-09-12 2021-03-18 Fim Biotech Gmbh Poröses Magnesiumoxidcarbonat zur Verwendung als Mittel zur Bindung von Phosphaten im Dünndarm mit dem Ziel der Reduzierung von nichtübertragbaren Krankheiten
JP7340572B2 (ja) * 2021-08-20 2023-09-07 セトラスホールディングス株式会社 酸化マグネシウム錠剤
KR102588239B1 (ko) * 2021-12-22 2023-10-12 알고케어 주식회사 기둥 형상의 제형을 제공하는 디스펜서
JP7507185B2 (ja) 2022-02-03 2024-06-27 セトラスホールディングス株式会社 錠剤収納容器

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4937026B1 (fr) * 1969-03-07 1974-10-04
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
DE4444052A1 (de) * 1994-12-10 1996-06-13 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
CN1262278C (zh) * 2001-08-27 2006-07-05 协和化学工业株式会社 抗酸·缓泻用片剂
JP4015485B2 (ja) * 2001-08-27 2007-11-28 協和化学工業株式会社 制酸・緩下用錠剤
SE0203065D0 (sv) * 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
WO2005044223A1 (fr) * 2003-11-07 2005-05-19 Takeda Pharmaceutical Company Limited Comprime a macher
EP1905430A4 (fr) * 2005-07-08 2012-08-01 Takeda Pharmaceutical Comprime
EP1967184A4 (fr) * 2005-12-28 2011-02-16 Takeda Pharmaceutical Preparation solide a liberation controlee
WO2009071219A2 (fr) * 2007-12-08 2009-06-11 Bayer Schering Pharma Aktiengesellschaft Comprimé dispersible oral

Also Published As

Publication number Publication date
BR112012005163A2 (pt) 2016-05-03
RU2012113740A (ru) 2013-10-20
RU2501561C1 (ru) 2013-12-20
CA2772750A1 (fr) 2011-03-17
JPWO2011030659A1 (ja) 2013-02-07
TWI466689B (zh) 2015-01-01
EP2476423A4 (fr) 2014-02-19
CN102481315B (zh) 2014-11-19
US20120156293A1 (en) 2012-06-21
WO2011030659A1 (fr) 2011-03-17
KR101560438B1 (ko) 2015-10-14
JP5696050B2 (ja) 2015-04-08
TW201109042A (en) 2011-03-16
KR20120064071A (ko) 2012-06-18
CN102481315A (zh) 2012-05-30
AU2010293637B2 (en) 2015-12-03
EP2476423A1 (fr) 2012-07-18
MX2012002789A (es) 2012-06-01
AU2010293637A1 (en) 2012-03-22

Similar Documents

Publication Publication Date Title
HK1171381A1 (en) Antacid and laxative tablet
GB2474903B (en) Improvements in security devices
EP2465539A4 (fr) Composition de particules se désintégrant et comprimé se désintégrant rapidement dans la cavité buccale
IL216955A0 (en) Medical devices and methods
EP2420178A4 (fr) Dispositif endoscopique et endoscope
EP2515946A4 (fr) Nanoconjugués et compositions de nanoconjugués
PL2469142T3 (pl) Złączka zaciskowa i jej zastosowanie
ZA201106702B (en) Sceletium extract and uses thereof
HK1221478A1 (zh) 變體及其用途
EP2471799A4 (fr) Complexe de terre rare et ses utilisations
EP2465540A4 (fr) Composition de particules se désintégrant et comprimé se désintégrant rapidement dans la cavité buccale
ZA201200366B (en) 3-cyanoquinoline tablet formulations and uses thereof
ZA201200761B (en) Tablet
ZA201200079B (en) Pharmaceutical compositions and solid forms
EP2418970A4 (fr) Extraction et utilisation de composés phénoliques
AU330360S (en) Tablet
EP2422771A4 (fr) Comprimé et pilons pour celui-ci
GB0912744D0 (en) Methods and uses
HK1170277A1 (en) Medicinal agent case
HK1167324A1 (zh) 壓制包衣的口腔崩解片
PL2507045T3 (pl) Brykieciarka i jej zastosowanie
GB0920041D0 (en) Tablet
GB2476228B (en) Improvements in security devices
GB0900329D0 (en) Improvements in anti-ligature devices and methods
GB0906703D0 (en) Excipients and their use

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180820